RedHill Biopharma and IntelGenx Announce First European Marketing Approval of RIZAPORT(TM) (RHB-103) for Migraines
Go back to RedHill Biopharma and IntelGenx Announce First European Marketing Approval of RIZAPORT(TM) (RHB-103) for Migraines| IntelGenx Technologies Corp. (AMEX: IGXT) | Delayed: 0.17 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.17 | 52 Week High | $1.00 | |||
| Open | $0.00 | 52 Week Low | $0.37 | |||
| Day High | $0.17 | P/E | N/A | |||
| Day Low | $0.17 | EPS | $-0.03 | |||
| Volume | 1,130,000 | |||||
| REDHILL BIO SP ADS (NASDAQ: RDHL) | Delayed: 0.84 +0.03 (3.70%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.81 | 52 Week High | $16.54 | |||
| Open | $0.83 | 52 Week Low | $8.10 | |||
| Day High | $0.87 | P/E | N/A | |||
| Day Low | $0.81 | EPS | $0.00 | |||
| Volume | 161,590 | |||||
